Healthcare provider profile · identity verified

Douglas A Degler, MD

Internal Medicine · EAST STROUDSBURG, PA · NPI 1760432520

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	516	169
Amlodipine Besylate	Amlodipine Besylate	375	112
Levothyroxine Sodium	Levothyroxine Sodium	333	107
Rosuvastatin Calcium	Rosuvastatin Calcium	332	117
Lisinopril	Lisinopril	206	67
Metoprolol Succinate	Metoprolol Succinate	198	67
Metformin Hcl	Metformin Hcl	164	54
Losartan Potassium	Losartan Potassium	154	50
Montelukast Sodium	Montelukast Sodium	149	49
Tamsulosin Hcl	Tamsulosin Hcl	149	46
Valsartan	Valsartan	141	39
Simvastatin	Simvastatin	137	41
Pantoprazole Sodium	Pantoprazole Sodium	135	52
Gabapentin	Gabapentin	127	44
Duloxetine Hcl	Duloxetine Hcl	123	33
Escitalopram Oxalate	Escitalopram Oxalate	117	40
Furosemide	Furosemide	107	41
Omeprazole	Omeprazole	104	38
Potassium Chloride	Potassium Chloride	103	28
Fluticasone Propionate	Fluticasone Propionate	100	41
Hydrochlorothiazide	Hydrochlorothiazide	98	42
Xarelto	Rivaroxaban	95	14
Prednisone	Prednisone	93	44
Sertraline Hcl	Sertraline Hcl	89	33
Atenolol	Atenolol	85	25
Eliquis	Apixaban	85	24
Albuterol Sulfate Hfa	Albuterol Sulfate	78	35
Bupropion Xl	Bupropion Hcl	73	20
Lorazepam	Lorazepam	65	30
Allopurinol	Allopurinol	62	18
Metoprolol Tartrate	Metoprolol Tartrate	61	22
Chlorthalidone	Chlorthalidone	60	20
Famotidine	Famotidine	60	18
Clopidogrel	Clopidogrel Bisulfate	57	23
Alprazolam	Alprazolam	56	25
Jardiance	Empagliflozin	56	18
Alendronate Sodium	Alendronate Sodium	55	16
Finasteride	Finasteride	53	17
Tramadol Hcl	Tramadol Hcl	51	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	11
Synthroid	Levothyroxine Sodium	41	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	13
Oxycodone Hcl	Oxycodone Hcl	40	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Carvedilol	Carvedilol	38	14
Ibandronate Sodium	Ibandronate Sodium	37	14
Spironolactone	Spironolactone	36	12
Donepezil Hcl	Donepezil Hcl	35	11
Mirtazapine	Mirtazapine	35	13
Nystatin	Nystatin	35	16
Pravastatin Sodium	Pravastatin Sodium	35	11
Torsemide	Torsemide	35	12
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Trazodone Hcl	Trazodone Hcl	33	15
Zolpidem Tartrate	Zolpidem Tartrate	30	16
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Pregabalin	Pregabalin	28	12
Doxycycline Hyclate	Doxycycline Hyclate	26	13
Meloxicam	Meloxicam	26	suppressed
Risedronate Sodium	Risedronate Sodium	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	11
Glimepiride	Glimepiride	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Ozempic	Semaglutide	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	11
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Valacyclovir	Valacyclovir Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Cephalexin	Cephalexin	19	18
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Meclizine Hcl	Meclizine Hcl	18	13
Metformin Hcl Er	Metformin Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Ezetimibe	Ezetimibe	16	suppressed
Dexamethasone	Dexamethasone	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Naproxen	Naproxen	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Colchicine	Colchicine	14	suppressed
Diazepam	Diazepam	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Klor-Con M10	Potassium Chloride	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Primidone	Primidone	12	suppressed
Ramipril	Ramipril	12	suppressed
Risperidone	Risperidone	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error